3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Melanoma
29
Neoplasms
10
Brain Neoplasms
6
Neoplasm Metastasis
3
Thyroid Neoplasms
2
Thyroid Cancer, Papillary
2
Skin Neoplasms
2
Multiple Myeloma
2
Hematologic Neoplasms
2
Glioma
2
Carcinoma, Non-Small-Cell Lung
2
Thyroid Carcinoma, Anaplastic
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Oligodendroglioma
1
Nonseminomatous germ cell tumor
1
Neurofibroma, Plexiform
1
Neurocytoma
1
Neuroblastoma
1
Lymphoma
1
Leukemia, Hairy Cell
1
Histiocytosis, Langerhans-Cell
1
Glioblastoma
1
Gastrointestinal Stromal Tumors
1
Ganglioneuroma
1
Ganglioglioma
1
Fever
1
Differentiated Thyroid Cancer (DTC)
1
Colorectal Neoplasms
1
Biliary Tract Neoplasms
1
Astrocytoma
1
Interventions
Cisplatin
9
Cetuximab
6
Radiotherapy, Intensity-Modulated
5
Docetaxel
4
Radiotherapy
3
Fluorouracil
3
Carboplatin
3
pembrolizumab
2
durvalumab
2
Radiation
2
Hydroxyurea
2
Drug Therapy
2
Celecoxib
2
Bupropion
2
130-nm albumin-bound paclitaxel
2
1,2-diaminocyclohexaneplatinum II citrate
2
sodium thiosulfate
1
gossypol acetic acid
1
Varenicline
1
Transcutaneous Electric Nerve Stimulation
1
Tobacco Use Cessation Devices
1
Psychiatric Rehabilitation
1
Polymerase Chain Reaction
1
Platinum
1
Pilocarpine
1
Oral Hygiene
1
Nicotine Replacement Therapy
1
Nicotine
1
NVP-BKM120
1
Immunoglobulin G
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Laryngeal Neoplasms
×
dabrafenib
×
Clear all
No trials found.